Early trial tests new combo for Tough-to-Treat cervical cancer
NCT ID NCT04651127
Summary
This early-stage trial tested a combination of two drugs, toripalimab and chidamide, for women with advanced cervical cancer that had returned or spread after standard chemotherapy. The goal was to see if this new drug pair could control the cancer better than existing options and to check its safety. The study was very small and was terminated early, so its full results are unknown.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Centre
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.